Buys
Open market- Shares
- Avg price
- Total value
Herriot Tabuteau - Chief Executive Officer, Director, 10%+ Owner at Axsome Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director, 10%+ Owner
- Issuer ticker
- AXSM on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Herriot Tabuteau in Axsome Therapeutics, Inc.
Sells
Open market- Shares
- -673,000
- Avg price
- $164.31
- Total value
- -$110,582,644
Net
Past year- Shares
- -673,000
- Share %
- -100%
- Total value
- -$110,582,644
Reported holdings for Herriot Tabuteau in Axsome Therapeutics, Inc.
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Axsome Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 7,344,500
- Estimated value
- $1,797,713,265
- Report date
- 05 Aug 2026
- Price
- $244.77
- Ownership
- Indirect
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Axsome Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 54,623
- Estimated value
- $3,749,782
- Report date
- 26 Feb 2026
- Price
- $131.07
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Axsome Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 7,229
- Estimated value
- $1,546,644
- Report date
- 06 Aug 2026
- Price
- $213.95
- Ownership
- Direct
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Axsome Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- $305,172
- Report date
- 06 Aug 2026
- Price
- $3.50
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Axsome Therapeutics, Inc.
- Security class
- Performance Stock Units
- Shares / value
- 24,081
- Estimated value
- Report date
- 21 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Herriot Tabuteau in Axsome Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.